Fetal Endoscopic Surgery for Spina Bifida (FESSB)

Vall d'Hebron University Hospital (HUVH)

Status: Enrolling

Conditions: Hydrocephalus; Neural Tube Defects; Spina Bifida, Open; Congenital Abnormality; Chiari Malformation Type 2; Fetal Disease; Myelomeningocele; Surgery; Maternal, Uterus or Pelvic Organs, Affecting Fetus

Treatments: Procedure: Fetoscopic repair of spina bifida

Study type: Interventional

Funder types: Other

Identifiers

NCT03315637

PR(AMI)152/2015

Details and patient eligibility

About

This study aims to assess the feasibility to perform a fetoscopic prenatal repair of an open neural tube defect, and secondly to assess the maternal, fetal and neonatal outcomes.

Full description

Introduction:

Spina bifida is a congenital malformation characterized by a failure in neural tube closure. Unprotected fetal neural tissue at the spine level undergoes not only progressive neurodegeneration in spinal cord, but also the impairment in brain development, hindbrain herniation or Chiari II malformation probably due to pressure disturbances resulting from a continuous leakage of cerebrospinal fluid through the defect. The neurological consequences at birth are irreversible and sometimes devastating, including paraplegia, sphincter urinary and fecal incontinence, hydrocephalus, cranial nerve disturbances, respiratory problems and death due to spinal cord injury and brain maldevelopment.

Intrauterine fetal open repair of the defect has proved to improve hindbrain herniation and decrease the need of cerebrospinal shunting.

Hypothesis:

The investigators hypothesize that minimally invasive surgery of spina bifida is feasible and may minimize surgical aggression and obstetrical complications, with similar neonatal and neurological results.

Intervention:

In this study the investigators propose a fetoscopic skin closure technique. After a maternal laparotomy the uterus is exteriorized, the amniotic cavity is accessed by fetoscopic approach. The placode is dissected from the surrounding tissue and dropped into the opened spinal canal, untethered. Part of the cystic tissue is resected. The edges are then closed to the midline.

Follow up:

After surgery patients are followed up at the Fetal Medicine Unit every one or two weeks.

The mode of delivery is decided according to obstetric criteria. Neonates will be examined at birth, and followed up regularly at least until 30 months. Patients are lifetime followed up by our Multidisciplinary myelomeningocele (MMC) Committee that comprises professionals from the Spina Bifida Unit, Neonatologists, Pediatric Surgeons, Pediatric Urologist, Pediatric Orthopedic Surgeons, Radiologists, Rehabilitation, Pathologists, Pediatric Neurosurgeons, Obstetricians and Fetal Therapists.

Enrollment: 50 estimated patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Maternal age > 18 years old
• Singleton pregnancy
• Gestational age between 18 0/7 weeks and 26 6/7 weeks
• Isolated neural tube defect between T1 and S1
• Cerebellar herniation (Chiari type II)

Exclusion criteria

• Fetal anomalies non related to neural tube defect (NTD) including chromosomal abnormalities
• Body mass index > 35 kg/m2
• Maternal disorders contraindicating surgery
• Genetic anomalies with poor prognosis
• Sever kyphosis (>30º)

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Fetoscopic repair of spina bifida

Experimental group

Description:

This is a single arm study, all patients will receive a fetoscopic repair of the spina bifida

Treatment:

Procedure: Fetoscopic repair of spina bifida